Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FL4R9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,665
Award facts
- Contract value 100% obligated
- $76,665.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $76,665.27 for 60-count tablets of Otezla 30 mg on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract involves no set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to compete successfully in open federal procurement. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania.
This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. Otezla (apremilast) is a systemic immunosuppressive medication used primarily for treating moderate to severe plaque psoriasis and psoriatic arthritis. As the prime contractor under the SPE2DX vehicle, AmerisourceBergen supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare programs worldwide. The DLA Troop Support Medical procurement vehicle enables flexible pharmaceutical sourcing to meet the varied medical supply requirements of military healthcare networks.
Quick answers
Who was awarded contract SPE2DB26FL4R9?
SPE2DB26FL4R9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FL4R9 worth?
The government has obligated $76,665 on SPE2DB26FL4R9.
Is contract SPE2DB26FL4R9 an order under another contract?
Yes. SPE2DB26FL4R9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL4R9 competed?
The extent of competition for SPE2DB26FL4R9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award